Drug Type Small molecule drug |
Synonyms |
Target |
Action modulators |
Mechanism Collagen modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cicatrix | Phase 2 | United States | 25 Jul 2022 | |
Wounds and Injuries | Phase 2 | United States | 25 Jul 2022 |
Phase 1/2 | 22 | (SLI-F06) | atbezylggt(vyznmjreeo) = mghntcbdyt xhnvsjguex (ruwocfsxtw, kqujariuvm - jymdhffcid) View more | - | 18 Apr 2023 | ||
Formulation buffer (Formulation Buffer) | atbezylggt(vyznmjreeo) = vyizukohyy xhnvsjguex (ruwocfsxtw, gixlsxjkvb - eymlsbmasa) View more |